Table S1. Extended patient characteristics.
Age (years) | Study group | Gender | Smoking | Cardiovascular disease | Autoimmune disease | Diabetes |
---|---|---|---|---|---|---|
69* | SE | Female | Yes | No | No | No |
58* | SE | Male | No | No | No | No |
59* | SE | Male | No | No | No | No |
52* | SE | Male | Yes | Yes | No | No |
61* | SE | Male | No | No | No | No |
24* | SE | Male | No | No | No | No |
70 | SE | Male | No | Yes | No | Yes |
53 | SE | Female | Yes | No | No | No |
53 | SE | Female | No | No | No | No |
69 | SE | Male | No | No | No | No |
23 | SE | Female | No | No | No | No |
65 | SE | Female | No | No | No | No |
55 | SE | Female | No | No | No | No |
42 | SE | Female | No | No | No | No |
47 | SE | Male | No | No | No | No |
64 | SE | Female | No | Yes | No | No |
61 | SE | Female | No | No | No | No |
47 | SE | Female | Yes | No | No | No |
59 | SE | Female | No | No | Yes | No |
67* | BE | Male | No | No | No | No |
68* | BE | Male | No | No | No | No |
67* | BE | Male | No | Yes | No | No |
48* | BE | Male | Yes | No | No | No |
74* | BE | Male | No | Yes | No | No |
69* | BE | Female | Yes | Yes | No | No |
57 | BE | Female | No | No | No | Yes |
63 | BE | Female | Yes | No | No | No |
67 | BE | Female | No | No | No | No |
50 | BE | Female | No | No | No | No |
48 | BE | Male | Yes | No | No | No |
59 | BE | Male | No | No | No | No |
42 | BE | Female | No | No | No | No |
61 | BE | Male | No | No | No | No |
59 | BE | Male | No | No | No | No |
70 | BE | Male | No | No | No | No |
25 | BE | Male | No | No | No | No |
68 | BE | Female | No | No | No | No |
25 | BE | Male | No | No | No | No |
65 | BE | Male | No | No | No | No |
59 | BE | Female | No | No | No | No |
60 | BE | Male | No | Yes | No | No |
67 | BE | Male | No | Yes | No | No |
75 | BE | Male | No | Yes | No | No |
55 | BE | Male | No | No | No | No |
73 | BE | Male | No | No | Yes | No |
44 | BE | Male | Yes | No | No | No |
68* | HGD | Male | Yes | No | No | Yes |
53* | HGD | Female | Yes | No | No | No |
70* | HGD | Male | No | No | No | No |
68* | HGD | Male | No | No | No | No |
51* | HGD | Male | Yes | No | No | No |
69* | HGD | Male | No | No | No | No |
74 | HGD | Female | No | Yes | No | Yes |
62 | HGD | Female | No | No | No | Yes |
62 | HGD | Male | Yes | No | No | Yes |
67 | HGD | Male | No | Yes | No | Yes |
65 | HGD | Male | No | No | No | Yes |
71 | HGD | Male | No | No | No | No |
58 | HGD | Male | Yes | Yes | Yes | No |
42 | HGD | Female | No | No | No | No |
82 | HGD | Male | No | No | No | No |
69 | HGD | Male | No | Yes | No | No |
75 | HGD | Male | No | No | No | No |
61* | EAC | Male | No | No | No | No |
65* | EAC | Female | Yes | No | No | No |
73* | EAC | Male | No | No | Yes | No |
66* | EAC | Male | No | No | No | No |
64* | EAC | Male | Yes | Yes | No | No |
46* | EAC | Male | No | Yes | No | No |
*, samples used for the Nanostring array. SE, squamous epithelium; BE, Barrett’s metaplasia; HGD, high-grade dysplasia.